Loading…
Relapsed 6q24-related transient neonatal diabetes mellitus successfully treated with sulfonylurea
[...]we report a Chinese male patient with a history of 6q24-related TNDM (hypomethylation of the maternal allele) who relapsed at 14 years old and was successfully treated with a low dose of glimepiride. Whole exome sequencing revealed no mutations. [...]the patient was treated with Lantus (8 U/day...
Saved in:
Published in: | Chinese medical journal 2019-04, Vol.132 (7), p.846-848 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [...]we report a Chinese male patient with a history of 6q24-related TNDM (hypomethylation of the maternal allele) who relapsed at 14 years old and was successfully treated with a low dose of glimepiride. Whole exome sequencing revealed no mutations. [...]the patient was treated with Lantus (8 U/day) together with lifestyle modifications. [2] Given that patients with 6q24-related TNDM have relatively healthy beta cell function at remission, sulfonylurea treatment has a biological rationale in patients with 6q24-related TNDM, as its potential mechanisms are: (1) patients with 6q24-related TNDM presumably have intact sulfonylurea receptors at the pancreatic ß-cell and (2) the beta cells of patients with 6q24-related TNDM have decreased sensitivity to glucose, so sulfonylurea helps to improve the release of insulin. |
---|---|
ISSN: | 0366-6999 2542-5641 |
DOI: | 10.1097/CM9.0000000000000147 |